NAFLOCORT ANHYDROUS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C29H33FO4
Molecular Weight	464.5683
Optical Activity	UNSPECIFIED
Defined Stereocenters	8 / 8
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(CC6=C(C2)C=CC=C6)C(=O)CO

InChI

InChIKey=IAHHOCLLSLZUNW-LDLSTMIQSA-N

InChI=1S/C29H33FO4/c1-26-10-9-21(32)12-19(26)7-8-22-23-13-20-11-17-5-3-4-6-18(17)14-28(20,25(34)16-31)27(23,2)15-24(33)29(22,26)30/h3-6,9-10,12,20,22-24,31,33H,7-8,11,13-16H2,1-2H3/t20-,22+,23+,24+,26+,27+,28-,29+/m1/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4074443 | https://www.kegg.jp/entry/D05104

Naflocort (SQ 26,490) is a topical anti-inflammatory adrenocortical steroid. It was a moderately potent inhibitor of edema formation in the rat. After extended topical application, SQ 26,490 totally inhibited edema formation without appreciable production of skin atrophy, measured under identical conditions. SQ 26,490 possesses the property for a greater separation of anti-inflammatory and atrophogenic activities than comparative corticoids.

Originator

Approval Year

PubMed

Title	Date	PubMed
Characterization of the anti-inflammatory activity and reduced potential for dermal atrophy of (11 beta, 16 beta)-9-fluoro-1',2',3', 4'-tetrahydro-11,21-dihydroxypregna-1,4-dieno[16,17-b]naph thalene-3, 20-dione hydrate (1 : 1) (SQ 26,490), a topically active corticoid.	1985	4074443

Patents

Sample Use Guides

In Vivo Use Guide

extended topical application

Route of Administration: Topical

Name

Type

Language

NAFLOCORT ANHYDROUS

Common Name

English

2'H-NAPHTHO(2',3':16,17)PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-1',4'-DIHYDRO-11,21-DIHYDROXY-, (11.BETA.,16.BETA.)-

Systematic Name

English

SQ-26490 ANHYDROUS

Code

English

naflocort [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C521